- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Darya-Varia Laboratoria Tbk (DVLA)
Darya-Varia Laboratoria Tbk stock price live, this page displays JK DVLA stock exchange data. View the DVLA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Darya-Varia Laboratoria Tbk real time stock price chart below.
What Is the Darya-Varia Laboratoria Tbk Stock Price Today?
The Darya-Varia Laboratoria Tbk stock price today is 1,585.
What Is the Stock Symbol for Darya-Varia Laboratoria Tbk?
The stock symbol for Darya-Varia Laboratoria Tbk is "DVLA."
What Stock Exchange Does Darya-Varia Laboratoria Tbk Trade On?
Darya-Varia Laboratoria Tbk is listed and trades on the Jakarta stock exchange.
Is Darya-Varia Laboratoria Tbk a Good Stock to Buy?
Determining whether Darya-Varia Laboratoria Tbk—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVLA quote. (ISIN: ID1000117203)
What Is the Darya-Varia Laboratoria Tbk Stock Price Today?
The Darya-Varia Laboratoria Tbk stock price today is 1,585.
What Is the Stock Symbol for Darya-Varia Laboratoria Tbk?
The stock symbol for Darya-Varia Laboratoria Tbk is "DVLA."
What Stock Exchange Does Darya-Varia Laboratoria Tbk Trade On?
Darya-Varia Laboratoria Tbk is listed and trades on the Jakarta stock exchange.
Is Darya-Varia Laboratoria Tbk a Good Stock to Buy?
Determining whether Darya-Varia Laboratoria Tbk—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVLA quote. (ISIN: ID1000117203)
Jakarta
Currency in IDR
1,585
-5(-0.31%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,585
1,600
52 wk Range
1,450
1,715
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,5851,600
52 wk Range
1,4501,715
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(6.60%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(6.60%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DVLA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Earnings
Latest Release
Jul 30, 2026
EPS / Forecast
34.56 / --
Revenue / Forecast
613.8B / --
Compare DVLA to Peers and Sector
Metrics to compare | DVLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDVLAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.0x | 10.1x | −0.4x | |
PEG Ratio | −0.94 | 0.03 | 0.00 | |
Price/Book | 1.2x | 1.2x | 2.6x | |
Price / LTM Sales | 0.8x | 1.0x | 3.1x | |
Upside (Analyst Target) | - | 50.5% | 48.8% | |
Fair Value Upside | Unlock | 36.8% | 5.7% | Unlock |
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. It also provides prescription products for various therapeutic areas, including cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. In addition, the company offers toll manufacturing services for soft gelatin capsules, as well as sterile injections and low volume solid products. It also exports its products. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk operates as a subsidiary of Blue Sphere Singapore Pte. Ltd.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Darya-Varia (DVLA) Stock Price Today?
The Darya-Varia stock price today is 1,585 IDR.
What Stock Exchange Does Darya-Varia Trade On?
Darya-Varia is listed and trades on the Jakarta Stock Exchange.
What Is the Stock Symbol for Darya-Varia?
The stock symbol for Darya-Varia is "DVLA."
Does Darya-Varia Pay Dividends? What’s The Current Dividend Yield?
The Darya-Varia dividend yield is 6.6%.
What Is the Darya-Varia Market Cap?
As of today, Darya-Varia market cap is 1.78T IDR.
What Is Darya-Varia's Earnings Per Share (TTM)?
The Darya-Varia EPS (TTM) is 122.
From a Technical Analysis Perspective, Is DVLA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Darya-Varia Stock Split?
Darya-Varia has split 2 times.
How Many Employees Does Darya-Varia Have?
Darya-Varia has 1357 employees.
What is the current trading status of Darya-Varia (DVLA)?
As of Aug 09, 2026, Darya-Varia (DVLA) is trading at a price of 1,585 IDR, with a previous close of 1,590 IDR. The stock has fluctuated within a day range of 1,585 IDR to 1,600 IDR, while its 52-week range spans from 1,450 IDR to 1,715 IDR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.